The parents of Kinaan Dadou, a 10-year-old Palestinian boy severely injured by a Hamas rocket on 7 October 2023, are still seeking funding for specialist treatment, the Guardian reported on 1 November. A proposed programme in Turkey would cost about $250,000, beyond the family’s means.
Kinaan was outside his family’s home near Bethlehem in the occupied West Bank when shrapnel struck his head. According to the Guardian, the rocket had been aimed at the nearby Israeli settlement of Efrat. His parents took him to hospital themselves, where the report says a doctor did not arrive for six hours amid the chaos of that day.
The newspaper describes Kinaan as being in a persistent vegetative state. He receives food through a tube and breathes through a tracheostomy. A specialist in Turkey said further surgery and intensive rehabilitation could improve his condition, but recovery is not assured.
The family lives in Um Rukbeh, in Area C of the West Bank, under Israeli military control. The Palestinian Authority administers healthcare for Palestinians there and supported Kinaan’s early treatment, including brain surgery. His parents say it has since declined to fund additional specialist care and has supplied medication inconsistently.
Israeli authorities told the family’s lawyer that Kinaan was injured outside their jurisdiction, the Guardian reported. The family disputes that position, pointing to Israel’s control over their daily lives. Neither the Palestinian health ministry nor Cogat, the Israeli body overseeing the Palestinian territories, answered the newspaper’s questions.
Kinaan’s father, Alaa Hassan Yakoub Dadou, says medication alone costs 4,000 shekels a month. He lost access to work in Israel after restrictions on Palestinian work permits following the attack. Kinaan’s mother, Woroud Dadou, now performs some routine care herself to reduce expenses. His parents say their aim is to ease his suffering, even if he never returns to his former condition.
Reader comments (0)
Bring evidence, ask questions, or challenge our reporting. Every comment is checked before publication.
No approved comments yet
Be the first to ask a thoughtful question or contribute useful context. We won't invent reader conversations.
Join the discussion
Members-only commenting
Everyone can read comments. To write, verify your email and sign in to your free member account.
Sign in or join freeNo newsletter subscription is required. Your email address remains private.